Name | 2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether |
---|
Description | HBDDE, a derivative of Ellagic acid, is an isoform-selective PKCα and PKCγ inhibitor with IC50s of 43 μM and 50 μM, respectively. HBDDE shows selective for PKCα/PKCγ over PKCδ, PKCβI and PKCβII isozymes. HBDDE induces neuronal apoptosis[1][2]. |
---|---|
Related Catalog | |
Target |
PKCα:43 μM (IC50) PKCγ:50 μM (IC50) |
In Vitro | HBDDE (50 μM; 5 hours) treatment reduces cell viability significantly by ~70%. HBDDE exhibits a marked increase in caspase-3 activity[1]. Cell Viability Assay[1] Cell Line: Cerebellar granule cells Concentration: 50 μM Incubation Time: 5 hours Result: Reduced cell viability significantly by ~70%. |
References |
Melting Point | 165-168℃ |
---|---|
Molecular Formula | C16H18O8 |
Molecular Weight | 338.31 |